Pfizer hikes U.S. prices of 91 drugs by average 20% in 2017

Reuters

2 June 2017 - Pfizer  has hiked the price of nearly a hundred drugs by an average of 20% so far this year in the United States, the Financial Times reported on Friday.

The U.S drugmaker raised the list price of 91 medicines – including that of its erectile dysfunction treatment, Viagra, and its pain drug, Lyrica – on June 1 by 5-13%, according to figures seen by the Financial Times.

Pfizer had also raised prices in January and, including those hikes, the average price of many of its drugs has risen by 20 this year, the Financial Times said.

Read Reuters article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing